PROMISE III Study for Chronic Limb-Threatening Ischemia

I'm Interested!

Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial

Sex at Birth: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Device
Trial Phase: NA
Conditions Being Studied: Critical Limb Ischemia (CLI)

Study Purpose

The purpose of this clinical study is to evaluate a device designed to create a connection between the artery and vein in the Below The Knee (BTK) vascular system using a minimally invasive approach.

Who Can Participate

Age: 18-98

Principal Investigator
Mehdi Shishehbor DO MPH PhD

Department/Division
Heart and Vascular (General Cardiology)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: SITE00001769
StudyID: 2022-0952
ClinicalTrials.gov: NCT05313165

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422